Product
CKD-383
3 clinical trials
2 indications
Indication
Type 2 DiabetesIndication
Type 2 Diabetes MellitusClinical trial
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between Administration of CKD-383 and Co-administration of CKD-501, D745, D150, and D029Status: Completed, Estimated PCD: 2023-07-23
Clinical trial
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150 for Healthy Subjects in Fed StateStatus: Completed, Estimated PCD: 2023-06-04
Clinical trial
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D745, and D150 for Healthy Subjects in Fed StateStatus: Completed, Estimated PCD: 2024-04-29